Please note: NECA will be closed from Friday 22nd December, reopening on Monday 8th January
Stay up to date on news and events, clinical trials and new research on neuroendocrine cancers.
NECA have been involved in the development of Guidelines for “ Biomarkers to Inform Prognosis and Treatment for Unresectable or Metastatic GEP-NENs” which is now
The 12th INCA Global NET Cancer Advocate Summit was held in Segovia Spain 9 -10 September 2024. The Summit saw representatives from 25 member organisations
This year’s theme, Accelerating Patient Access to New Medicines, encompassed a much of our advocacy work NECA have been doing with our VHL Patients to
Meredith Cummins, Dana Hart and Kahlia Wolsley attended the Australasian Association of Nuclear Medicine Specialists (AANMS) Theranostics Course 24th and 25th August at W Brisbane Hotel.
